Caprock Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$595K Buy
26,305
+4,036
+18% +$90.6K 0.01% 796
2026
Q1
$502K Buy
22,269
+12,867
+137% +$296K 0.01% 749
2025
Q4
$224K Buy
9,402
+471
+5% +$11.7K ﹤0.01% 1083
2025
Q3
$230K Buy
+8,931
New +$230K 0.01% 1022
2024
Q3
Sell
-10,879
Closed -$208K 933
2024
Q2
$208K Buy
+10,879
New +$222K 0.01% 795

Other funds holding FMS

Caprock Group's FMS Position: Q2 2026 in Review

Caprock Group increased its Fresenius Medical Care (FMS) stake by 18% in Q2 2026, buying an estimated $90.6K and bringing the position to 26,305 shares worth $595K. The position accounts for 0.01% of the portfolio, ranked #796.

Caprock Group first reported a position in FMS in Q2 2024 and has held it in 5 quarters since. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Caprock Group held 26,305 shares of Fresenius Medical Care worth $595K as of Q2 2026.
  • Caprock Group bought 4,036 Fresenius Medical Care shares in Q2 2026, an estimated $90.6K.
  • Fresenius Medical Care made up 0.01% of Caprock Group's portfolio in Q2 2026, its #796 holding.
  • Caprock Group first reported a position in Fresenius Medical Care in Q2 2024 and has held it in 5 quarters since.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.